CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $11.04, but opened at $11.81. CymaBay Therapeutics shares last traded at $11.82, with a volume of 39,919 shares changing hands. Analysts Set New Price Targets CBAY has been the subject of a […]
StockNews.com cut shares of CymaBay Therapeutics (NASDAQ:CBAY – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. A number of other equities research analysts have also recently commented on CBAY. Cantor Fitzgerald lifted their price objective on CymaBay Therapeutics from $13.00 to $15.00 in a research […]
StockNews.com downgraded shares of CymaBay Therapeutics (NASDAQ:CBAY – Free Report) from a hold rating to a sell rating in a research note issued to investors on Wednesday. CBAY has been the subject of several other research reports. HC Wainwright increased their target price on CymaBay Therapeutics from $10.00 to $12.00 in a research report on […]
CymaBay Therapeutics (NASDAQ:CBAY – Free Report) had its price objective hoisted by BTIG Research from $15.00 to $18.00 in a report released on Tuesday, FlyOnTheWall reports. Several other analysts also recently weighed in on CBAY. William Blair initiated coverage on shares of CymaBay Therapeutics in a research note on Wednesday, April 5th. They issued an […]
StockNews.com lowered shares of CymaBay Therapeutics (NASDAQ:CBAY – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. CBAY has been the subject of a number of other research reports. Oppenheimer raised their price target on shares of CymaBay Therapeutics from $10.00 to $12.00 and gave the […]